[YMAB] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
13-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -22.93%
YoY- 73.32%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 22,798 19,931 23,363 20,454 20,751 20,251 31,447 -19.31%
PBT -9,149 -6,469 -793 -7,560 -6,123 -6,390 1,157 -
Tax 100 160 195 187 179 -1,293 1,558 -83.99%
NP -9,249 -6,629 -988 -7,747 -6,302 -5,097 -401 711.82%
Tax Rate - - - - - - -134.66% -
Total Cost 32,047 26,560 24,351 28,201 27,053 25,348 31,848 0.41%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -40.57 -33.26 -4.23 -37.88 -30.37 -25.17 -1.28 903.64%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 -0.01 662.57%
EPS Diluted -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 -0.01 662.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.